Intel Corporation
Designs and manufactures computer processors, operating its own chip factories unlike most rivals that outsource production.
Trim 33-35% of INTC via market-on-close orders today given the MACD bearish cross (histogram at -1.56, peaked at +3.31 on 9/25), retaining ~65% residual for Q3 2026 earnings binary participation. Single structural stop at $102.81 (50 SMA close basis), with position sizing capped at 50% of normal high-conviction tech allocation given beta 2.23. No new short positions or put-spread hedges per the 10-06 binding lesson.
20 wins · 16 losses · 7 pushes in 43 scored verdicts How this is scored
Free accounts read most reports by the next trading session, every report within 7 days — subscribers read it the same day.
Create a free account+0.6%
Report archive
Subscribe to read
Subscribe to read
last 30 of 48 reports20 wins · 16 losses · 7 pushes in 43 scored verdicts+0.23% avg move
$10,000 → $10,056
+6.6%
$10,000 → $10,655
too few trades to judge — 1 round trip, 1 profitablein the market 1 of 44 sessionsmax drawdown -0.8%simulated 10 Aug – 9 Oct 20265 newer calls are locked
Simulated with a notional $10,000, fills at the next session's open, no commissions or slippage, split- and dividend-adjusted prices. Not a return forecast. How this is simulated
Subscribe to read
Subscribe to read
Subscribe to read
Trim 33-35% of INTC via market-on-close orders today given the MACD bearish cross (histogram at -1.56, peaked at +3.31 on 9/25), retaining ~65% residual for Q3 2026 earnings binary participation. Single structural stop at $102.81 (50 SMA close basis), with position sizing capped at 50% of normal high-conviction tech allocation given beta 2.23. No new short positions or put-spread hedges per the 10-06 binding lesson.
Trim 30% of INTC at ~$113 now rather than waiting for phantom resistance at $115-120; retain 70% through Q3 2026 earnings catalyst with a $105 tactical stop (closing basis, ~7% pre-earnings-close discipline) and re-entry zone of $99-108 if MACD histogram turns positive.
Trim INTC by 30% via market-on-close orders triggered by MACD histogram crossing zero, retaining 70% at no more than 50% of normal high-conviction weight. Dual-stop architecture (tactical stop at $107, structural invalidation at $99.85) protects the residual against the Q3 2026 earnings binary, with defined-risk Dec/Jan $100-110 put spreads sized at 1-1.5% of portfolio cost providing tail insurance without naked-short exposure on a beta-2.23 name.
Trim 30% of INTC exposure via scaled limit orders at $114-119, reducing residual to 70% sized at maximum 50% of normal high-conviction weight due to beta 2.23 and ATR $5.99. Deploy dual-stop architecture with tactical stop at $108 (~7% from $116 pre-earnings close basis) and structural invalidation at $99.85 (50 SMA close basis), whichever triggers first. Hedge via defined-risk Dec/Jan $100-110 put spreads at 1-1.5% of portfolio cost as tail insurance against the Q3 2026 earnings binary catalyst.
Trim 30% of INTC exposure at $114-118 (10 EMA zone) to address technical deterioration (MACD histogram -77%, RSI 73→61.5) and extreme 57.9x forward P/E, while retaining 70% residual for Q3 2026 earnings catalyst with a structural stop at $99.85 (50 SMA close basis); re-entry zone is $99-108 on constructive volume retest, with optional 3-month put protection recommended for binary catalyst risk management.
Analyst trims 30% of INTC exposure into the current $114-118 zone (10 EMA test) rather than holding full size into Q3 2026 earnings, maintaining Underweight rating despite the Q2 operating inflection being real—arguing it is already priced at 58x forward P/E on $2.06 EPS. The residual 70% position uses a single structural stop at $99.85 (50 SMA close basis), wider than the trader's exposed $112 stop, with re-entry at $99-108 on constructive volume and ~1-2% put hedge (Dec/Jan $110-115 strikes) as tail insurance.
Intel (INTC) is rated Underweight with a trim of 30% of existing exposure in the $114-118 zone, as the operating inflection is deemed real but already priced into the 58x forward P/E multiple following a 246% rally over the past year. A single structural stop at $99.85 (50 SMA close basis) defines the medium-term thesis invalidation level, with re-entry targeted at $99-108 on 20 SMA/50 SMA convergence with constructive volume, over a 4-6 week tactical horizon through the Q3 2026 earnings catalyst.
Intel faces a 30% position trim via scaled limit orders at $114-118 (10 EMA zone) rather than waiting for the $125-127 rally, locking in gains from the $89.51 entry base without requiring market cooperation; the residual 70% retains structural stop protection at $99.85 (50 SMA close basis) and a re-entry trigger zone at $99-108 on constructive volume through the Q3 2026 earnings catalyst over a 4-6 week tactical horizon.
Intel faces compressed risk/reward at 56x forward P/E with $37.7B net debt (+$10B QoQ) and 46% extension above the 200 SMA, justifying a 40% trim via scaled limit orders in the $118-127 zone rather than full exit. The 60% residual core is held with a hard structural stop at the 50 SMA ($99.47) to preserve asymmetric upside through Q3 2026 earnings while limiting downside to ~10% on original position if the $99.47 stop fires.
Maintain INTC at existing weight with a price target of $128 and a 2-4 week tactical horizon through Q3 2026 earnings. The single structural stop is a close below $115, and the single re-entry trigger is a pullback to the $104–115 zone with constructive daily-close volume permitting adds up to 25% of current sizing. Trim into $130+ on momentum exhaustion (RSI >75 with Bollinger upper-band extension).
Maintain INTC at $122.60 with no action—neither trimming nor adding—while preserving defined entry at $111, structural stop at $97.50 (50 SMA break), and tiered add rules at $111–$115 and $98–$101. The HOLD rating reflects binding lessons from 09-21 (30–40% trim cap on tier-1-validated names at maximum extension) and 09-17 (simplify multi-tier framework to single invalidation plus single re-entry trigger), both of which prohibit Buy at 59.45x forward P/E and prohibit Conservative's 10–15% trim proposal given structurally identical setup to prior costly decision.
Maintain INTC at $123.86 with HOLD rating—no trimming, no new initiation at current levels. Existing longs are protected by a hard stop at $97.75 (50 SMA close), while new capital should wait for a pullback to the $115 zone holding the rising 10 EMA on daily close before adding up to 50% conviction sizing. The 2-4 week tactical horizon targets Q3'26 earnings as the catalyst, with the operating inflection confirmed by Q2'26 fundamentals but execution risk (60.1x forward P/E, -$11B GAAP net income, $50.5B debt) warranting patience over aggression.
INTC rated UNDERWEIGHT with a recommendation to trim 50% of the existing position (in the 40-50% trim range), holding a residual sized to 0.45% portfolio risk at a $105 closing-basis stop. At $121.78 with a 59x forward P/E versus 2.4% upside to $124.73 resistance and 13.5%-20% downside to the 10 EMA at $105 and 50 SMA at $97, the technicals show window-maximum exhaustion (RSI 70.92, price +$5.81 above upper Bollinger, MACD histogram +2.56), and a binary Q3 print lands in ~5 weeks against tougher YoY comps on a beta-2.23 name. The operating inflection thesis is real and prevents full Sell, but the asymmetric entry overrides directional conviction at this price—trim, don't exit.
Maintain INTC at $108.60 on Hold as the +22% rally off September lows into 52.7x forward PE and declining 50 SMA presents poor risk/reward for new capital. Trail stop to $101.80 (10 EMA) with conditional ratchet to $105 on confirmed close above $110.68 on volume; trim 25% into $115 and another 25% into $125-130, trailing remainder to breakeven at $142. Re-enter at $95-97 (50 SMA zone) only with RSI above 50 and constructive basing pattern.
Maintain INTC with a tactical 20-25% trim into the $108-112 zone per the 09-16 binding reflection, which explicitly mandates a 70% residual floor when operating inflection has Tier-1 validation with rising 200 SMA—all three conditions met today. The trader's SELL recommendation is rejected as it contradicts the operating thesis and recent MACD bullish cross; the research plan's 40-50% trim is also rejected as miscalibrated against yesterday's -6.5% alpha destruction lesson from over-trimming an accelerating thesis. Stop loss set at $94 closing basis, with a 4-6 week time horizon through late-October earnings and SK Hynix binary catalyst resolution.
Analysts converge on Underweight for INTC but calibrate trim magnitude to 40-50% (not full exit, not hold), executing via two weakness-triggered tranches at $97 or $106.24 with momentum divergence, with stop at $90 on closing basis. The operating inflection pillars (EBITDA triple, NVIDIA stake, CEO insider buy) argue against full exit, while the SK Hynix binary catalyst and hostile macro justify the trim above the 30-40% floor established in prior lessons. Re-engagement to full weight requires one of four triggers: signed SK Hynix MOU, soft October Fed tone, Q3 EBITDA confirmation, or tier-1 18A foundry win.
Maintain INTC at 2-3% book weight as the binding-consistent synthesis—Q2's operating inflection (+25% YoY revenue, $3.26B operating income swing, $4.87B TTM FCF) is real but unproven sequentially, while 47.5x forward P/E on -19.8% TTM margin and a confirmed lower-high pattern ($142 → $82 → $106 → $97) into a hostile macro (19-year yield highs, recession odds +9pp, beta 2.23) create unfavorable conditions for fresh capital deployment. Execute rule-based sizing: scale to 4% only on confirmed close above $106.24 with volume >90M sustained 2-3 sessions; trim to 1% only on close below $82.40 on volume or hawkish FOMC surprise failing to hold $94.
Trim INTC exposure by ~40% to 60-65% of benchmark, executed in two tranches, with a stop moved from $106 to $94 (Bollinger middle band). The Underweight thesis rests on five independent fronts: stretched 47.5x forward P/E on negative EPS and declining revenue, confirmed technical distribution with lower-high formation and fading MACD, fully priced-in foundry/CHPS Act catalysts, structurally weak inference thesis losing share to AMD and ARM-based chips, and hostile macro conditions with 10Y at 5% and 94% no-cut odds. No hedge overlay is recommended as the 40% trim plus defined stop provides sufficient downside protection without decay drag.
Analysts recommend trimming 30–35% of INTC exposure into the $102–104 zone with a closing-basis stop at $94.61, maintaining Underweight until the 50 SMA flattens and curls higher or price reclaims $107.40 on volume >90M. The decision is anchored to a binding 09-10 reflection lesson that argued against expanding trim on an accelerating operational thesis — NVIDIA's 214M-share stake, SoftBank injections, Q2's 25.4% YoY revenue growth, and the CEO's $10M insider buy at $95 remain intact pillars supporting residual exposure.
Trim INTC exposure to 30-50% of current allocation in tranches (~25% near $104, ~15% via limit orders in $106-110 zone), with hard stop at $94. The bearish thesis rests on stretched valuation (49.1x forward P/E, 0.9% FCF yield on a $530B market cap up 188% YTD), deteriorating technicals (declining 50 SMA overhead resistance, September 10 reversal on 96M shares), and three institutional voices turning cautious in one week, all in a hostile macro regime with 93% probability of no Fed cuts in 2026. Re-engagement requires either a pullback to $85-92 with RSI below 45 and basing action, or a confirmed breakout above $106.24 on volume >110M with macro easing signal.
Trim ~30% of INTC exposure (in two tranches: 15% at market near $106, 15% via limit at $108-112 only if overhead supply rejects) with a hard stop at $94 daily close. The underweight call reflects a stretched forward P/E of 52x, hostile macro conditions (no Fed cuts, elevated WTI, rising yields), and four institutional walkbacks in one week, while the operating inflection thesis (Q2 +25.4% YoY revenue, 1,290 bps gross margin expansion, FCF swing to +$4.45B) and CEO insider buying at $95 support retaining residual exposure. Re-entry is targeted at pullback to $85-90 with RSI below 45, or breakout above $120 with volume >100M and macro easing signal.
Maintain HOLD on INTC at current levels (~$104) with no fresh capital deployment and no defensive trim, accepting the cost of leaving upside on the table to avoid the alpha destruction that aggressive trimming has produced 4 of 5 times in this decision sequence. The framework sets an add trigger at $100-102 (50 SMA retest), tiered profit-taking at $115-120 and $130, and explicit downgrade triggers (close below $100, official price hike denial, or material macro deterioration) with a hard stop at $91.91.
The Portfolio Manager upholds a HOLD rating on INTC with no position change, maintaining current exposure at ≤50–60% of normal semi allocation. The decision rejects both aggressive overweight (despite real thesis merit from Q2's +25.4% YoY revenue and 1,290 bps margin expansion) and conservative underweight/hedging (despite 46.9x forward P/E and macro risks), instead defaulting to patience pending price confirmation—either a close above $94.65 with volume confirming the coiled-spring breakout, or a test of the 200 SMA support at $73.57 with constructive price action. The hard stop at daily close below $73.57 triggers full exit, but no trim, hedge, or add is warranted until direction is confirmed.
Analysts maintain Underweight on INTC with a trim of 30-35% (compressed to lower end of the 1/3–1/2 range) to a 0.5x residual allocation, citing 12% price decline below the 50 SMA, negative MACD since early July, and 2.24 beta creating asymmetric downside risk in a no-cuts regime with 89% probability of zero 2026 Fed cuts. Execution uses a split mechanism—half at market near $90, half via limit orders at $94–96—while a stop on the residual sits at $82.81 (lower Bollinger Band); re-entry requires a weekly close above $94.65 on above-normal volume, reclaim of the 50-day SMA (~$102), AND MACD histogram turn positive, all three conditions simultaneously, over a 4-6 week horizon through Q3 2026 earnings.
Trim 30% of the INTC position via split execution (half at market ~$90, half on limit orders at $95-98) to capture current price while preserving upside optionality, with a hard stop at $82 on the residual position. No new initiation recommended ahead of the Q3 2026 earnings catalyst, with conditional re-engagement requiring either a confirmed 50 SMA reclaim at $102 on volume >100M shares or a structural 200 SMA test at $73 with constructive price action. Protective puts at the $80 strike (2-3% of residual position value) are recommended to hedge against foundry stumble or macro deterioration scenarios.
Initiate a measured Overweight position in INTC anchored in validated operating inflection (revenue +25.4% YoY, gross margins +13pp to 40.4%, FCF +$4.87B TTM) and multi-sigma insider clustering at the $95 zone, with price target $115 over 6-12 months; cap total exposure at 60% of full target weight with hard stop $79-80 closing basis.
Intel (INTC) remains Underweight with a 30-40% trim via scale-in execution into the $93-96 zone, targeting a residual of 60-70% of current position (sub-1% NAV cap). The $84 stop (lower Bollinger band / recent swing low) protects against breakdown while sitting above the $72-78 200 SMA structural floor. Re-engagement requires either a confirmed close above $104.92 on the 50 SMA with volume >100M shares, or a 200 SMA test at $72-75 with RSI divergence and constructive price action, with full thesis reassessment on Q3 2026 earnings if neither trigger fires within 60-90 days.
INTC is rated Underweight with a $72.26 price target over a 4-6 week horizon through Q3 2026 earnings validation. Execute a 30-40% trim at $89 compressing residual to sub-0.5% NAV, using a dual-threshold framework: re-evaluation halt if close exceeds $95 on volume, or accelerated trim trigger if close drops below the lower Bollinger band at $84.17, with hard residual floor at $72 (200 SMA closing basis). Single-condition re-entry: close above 10 EMA ($91.74) with rising volume for two consecutive sessions.
Maintain INTC position at 1.5-2% weight (compressed from 2-3% range) with hard stop at $84.29. Keep $72.50 conditional add level but require stabilization (close above 50 SMA or MACD bullish crossover) before scaling in. Upgrade trigger is confirmed close above $96 on volume with MACD histogram contraction. Time horizon 4-8 weeks through Jackson Hole + Q3 earnings resolution.
Execute an aggressive phased trim on INTC, selling 50-60% of the position now at ~$88 and reserving an additional 10-15% for a potential bounce to $93-95, capping residual at sub-0.5% NAV with a hard stop at $70 closing basis. Despite directional bearish consensus across all three analysts, the operating inflection (Q2 +25% YoY revenue, 40.4% gross margin, $4.45B FCF) and the 08-24 lesson against full exit ahead of binary catalysts support maintaining Underweight rather than converting to Sell.
Execute a phased Underweight trim on INTC — cut 50-60% of the position now at $87, reserve another 10-20% for any post-NVDA strength toward $93-95, and compress total residual to sub-0.5% NAV with a hard stop at $81.79. This calibration addresses two conflicting lessons: the 08-21 lesson (Underweight with 1%+ residual replicates Hold alpha drag, requiring compression to sub-0.5% NAV) and the 08-24 lesson (full Sell when catalyst is days-not-weeks away also produces alpha drag, requiring scaled conviction instead of full exit).
Full exit of INTC at ~$87 is recommended to avoid the alpha drag historically produced by residual exposure on this exact setup (2.24 beta, death cross, broken momentum, NVDA 8/27 binary catalyst); the prior 08-21 Underweight with 50% trim left 1% residual that nearly erased trim benefits, and the trader's current SELL-with-50-70%-trim replicates that operationally equivalent-to-Hold pattern. With gap risk unbounded through the $78 stop ($74-75 potential overnight gap) and upside capped by reduced size, full exit preserves capital for redeployment on five defined re-rating triggers.
Trim approximately 50% of INTC at ~$90, reducing residual to ~1% NAV, with hard stop at $79-80. Underweight rating reflects confirmed multi-EMA failure on a 2.24-beta name with 44x forward P/E perfection multiple, $35B+ cumulative impairments, and Druckenmiller's full exit — a combination that demands aggressive position compression despite Q2 2026's real FCF inflection ($4.45B in Q2, 40.4% gross margin).
Intel receives an Underweight rating with a 40% position trim recommended at current ~$92 levels due to unambiguous medium-term technical damage (multiple failed moving averages, MACD at -2.17) and weakened fundamental floor versus prior inflection points; the residual position carries a hard stop at $71.26 (200 SMA), with re-engagement requiring either 50 SMA reclaim above $108 with >100M shares volume or a tested floor at $80-85 with constructive price action. Price target is $85 over a 4-6 week horizon through Q4 earnings validation.
Trim INTC 50-60% of current position given 45x forward P/E vs -10.7% ROE and multiple bearish technical signals (price below 10 EMA, 50 SMA, VWAP with declining 50 SMA overhead), leaving residual at 30-40% of normal chip allocation with dollar risk capped at 1-1.5% of portfolio NAV at the $88 hard stop; re-engage only on confirmed 50 SMA breakout above $110 with >100M shares volume or a flush to $80-85.
Trim INTC 15-25% at current $96-99 levels over 1-3 sessions due to technically damaged setup (price below 10 EMA, 50 SMA, and VWAP; MACD histogram rolled over 30% from Aug 13 peak), while retaining core position with $84 structural hard stop. Consider additional 10-15% trim if price rallies to $104-109 on volume; new entrants should wait for $109.33 reclaim with 50 SMA turn-up. The neutral analyst's framework wins over extremes by acknowledging damage without panicking and respecting the fundamental floor (Q2 +25.4% YoY revenue, 40.4% gross margin) without being captive to it.
Maintain INTC at 2-3% NAV with a hard stop at $96.50, buy zone at $90-95, and breakout trigger at $111.50 on >150M shares volume. Hold current position without adding aggressively at $103.49 or trimming into strength, allowing Q3 2026 earnings to resolve the operational-inflection debate before upgrading or downgrading.
Intel (INTC) maintains a HOLD rating with a price target of $96.0 over a 3-6 month horizon anchored to Q3 2026 earnings and 18A node progress. The recommendation favors 0.5% portfolio sizing (vs. trader proposal of 1%) given ATR of $7.20 and beta of 2.24, with a hard exit trigger at close below $99.80 on expanding volume and tactical trims on rallies toward $109.40 on confirmed breakouts with volume.
Maintain INTC at 2-3% portfolio weight with $80 hard stop, pre-committing a 10-15% trim at $107-108 resistance (where 50 SMA and Bollinger upper band converge). Re-engage on either a confirmed breakout above $109.60 with volume exceeding 100M shares, or a pullback to the $80-85 zone near the 200 SMA for improved risk/reward. Q3 2026 earnings in early November serves as the validation event.
All three risk analysts converge on HOLD for INTC at $100.95, balancing verified operational inflection (Q2 +25% YoY revenue, +$4.45B FCF, 40.4% gross margin) against damaged technicals (price 8.72 below declining 50-day SMA, negative MACD) and stretched 49x forward P/E valuation. The appropriate expression is to wait for confirmed close above $108-110 with 50-day SMA retest before tactical accumulation, with hard stop at $84 and structural invalidation at $69.50.
Three analysts converge on a trim-to-underweight action given 47x forward P/E with negative TTM EPS, 17% YoY share count expansion, and bearish technicals (failed $109.84 50 SMA reclaims, negative MACD at -3.26). However, the +25.4% YoY revenue growth, 1,290 bps gross margin expansion to 40.4%, and +$4.45B FCF swing create a real operational floor that prevents a full Sell rating. The $102-104 stop zone is adopted from the neutral analyst — tighter than the trader's $110 (too tight for a 7.7% ATR, 2.24 beta name) and looser than the conservative's $86.40 (which converts a trim into a directional breakdown bet).
Reduce INTC to 35-40% of normal semiconductor allocation (volatility-adjusted ~70-80% of a typical semi position given 2.24 beta and $7.89 ATR) targeting the $90 price target. Hard exit below $81.88 (July crash low); trim into rallies in the $102-$105 zone with no new longs or synthetic exposure of any kind. Re-engagement requires sustained close above the 50 SMA ($110) for 5+ sessions with expanding volume AND either a verified 14A anchor customer announcement or Fed dovish pivot—Q3'26 October earnings is the critical re-evaluation event.
Reduce INTC by 40-50% given 1:3.7 asymmetric risk/reward against the $81.88 pivot, expanded net debt (+36% to $37.7B), and elevated beta (2.24) into a catalyst-dense August-September window. Hedge the residual 1-2% position with a cost-neutral collar, treating $81.88 as the structural invalidation level and $110.65 as the re-entry confirmation trigger on above-average volume.
Get the daily brief — how yesterday's calls actually scored, in your inbox before the open — free with a TraderPunk account.
Create a free accountAlready have one? Sign in to subscribe.